MedTrace Logo

Effects of Yangxinshi Pills on the Exercise Tolerance of the Patients With Coronary Heart Disease

NCT03478332 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2018-03-27

No results posted yet for this study

Summary

Compared with conventional treatment of the coronary heart disease,the aim of the research is to find out if the addition of Yangxinshi pills on the basis of conventional treatment can improve exercise tolerance of patients with coronary heart disease, improve quality of life or restore social function and mental health

Conditions

Interventions

DRUG

Yangxinshi pill

0.6g/tablet

DRUG

conventional coronary heart disease medicine

the conventional treatment includes medicines treating coronary heart disease

DRUG

Placebos

Yangxinshi simulant

Sponsors & Collaborators

  • Affiliated Hospital of Changchun University of Chinese Medicine

    lead OTHER

Principal Investigators

  • Xiaoping Meng, Doctor · Changchun Traditional Medicine University Affiliated Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2020-05-02
Completion
2020-08-25

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03478332 on ClinicalTrials.gov